|
Jul 28
|
Will These 5 Pharma/Biotech Bigwigs Surpass Q2 Earnings Forecasts?
|
|
Jul 28
|
2 Top Dividend Stocks to Buy Right Now and Hold Forever
|
|
Jul 28
|
Stocks Rise Pre-Bell as US, EU Strike Trade Deal; Investors Await Key Tech Earnings, Economic Data, Fed Policy Decision
|
|
Jul 28
|
Option Volatility And Earnings Report For July 28 – Aug 1
|
|
Jul 28
|
Guggenheim Reiterates a Buy Rating on AbbVie (ABBV) With a $216 PT
|
|
Jul 28
|
AbbVie (ABBV) Positioned for Growth With Strong Skyrizi, Rinvoq Sales, Says JPMorgan
|
|
Jul 26
|
The Smartest Dividend Stocks to Buy With $350 Right Now
|
|
Jul 26
|
Genmab A/S (GMAB) Opens U.S. Hub in New Jersey to Drive Global Growth
|
|
Jul 25
|
Mag 7 earnings, Fed meeting, PCE, jobs report: What to Watch
|
|
Jul 25
|
Stocks to watch next week: Microsoft, Apple, Shell, AstraZeneca and HSBC
|
|
Jul 24
|
J&J Innovative Medicine Unit Shines Again in Q2: Will This Continue?
|
|
Jul 24
|
The 3 Things That Matter for AbbVie Now
|
|
Jul 24
|
AbbVie Insiders Sell US$50m Of Stock, Possibly Signalling Caution
|
|
Jul 24
|
Behcet's Disease Market Research Report 2025-2035 | Key Trends, Regulatory Framework, Epidemiology, Clinical Trial Analysis, Market Dynamics
|
|
Jul 24
|
Diffuse Large B-cell Lymphoma Market Research Report 2025-2035 | Personalized Medicine and Precision Treatment Trends in DLBCL
|
|
Jul 24
|
iOnctura Strengthens Medical and Commercialization Expertise with Two Non-Executive Board Appointments
|
|
Jul 23
|
Rheumatologists Eye AbbVie’s Rinvoq, Roche/Genentech’s Gazyva, and Bristol Myers Squibb’s Sotyktu as Front-Runners to Address Persistent Gaps in Systemic Lupus Erythematosus Care, Spherix Global Insights Reports
|
|
Jul 23
|
Accelerating innovation in early Alzheimer’s disease diagnosis
|
|
Jul 23
|
Atopic Dermatitis Market Forecast Report 2025-2034 | FDA Approval of Tralokinumab-Ldrm Stimulates Treatment Advances
|
|
Jul 22
|
AbbVie (ABBV) Outperforms Broader Market: What You Need to Know
|